31 results on '"Pittman, Phillip R."'
Search Results
2. Rudolf Hess – The Doppelgänger conspiracy theory disproved
3. Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
4. Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
5. Safety and immunogenicity of ricin vaccine, RVEc™, in a Phase 1 clinical trial
6. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response
7. Anthrax vaccine adsorbed: Further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed
8. Chapter 13 - Biodefense Vaccines, Vaccines for Emerging Infectious Diseases, and Coalition for Epidemic Preparedness Innovations (CEPI)
9. 97 - Influenza Virus: A Public Health Concern
10. 95 - Severe Acute Respiratory Syndrome and Coronavirus Disease 2019
11. 91 - Tularemia
12. 90 - Anthrax
13. An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals
14. Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination
15. Monkeypox and pregnancy: correspondence
16. Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series
17. Contributors
18. Long-term health effects of repeated exposure to multiple vaccines
19. 12 - Biodefense and Special Pathogen Vaccines
20. Contributors
21. Aluminum-containing vaccine associated adverse events: role of route of administration and gender
22. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid
23. Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans
24. Anthrax vaccine: short-term safety experience in humans
25. Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans
26. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience
27. 41 - Biodefense and special pathogen vaccines
28. Contributors
29. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination
30. List of Contributors
31. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.